Good Manufacturing Practices licence granted

Company news

27 Oct 2020

LGP Manufacturing 1200x1200

Little Green Pharma was recently granted a Therapeutic Goods Administration (TGA) Good Manufacturing Practices (GMP) licence for its recently commissioned manufacturing facility in Western Australia. This license means:

  • LGP will now be able to produce medicinal cannabis flower products
  • LGP has the benefit of enhanced manufacturing capacity in addition to our existing pharmaceutical manufacturer
  • strong supply reliability for patients

The GMP licencing of the Company’s manufacturing facility is the culmination of a two-year regulatory strategy.

Little Green Pharma now holds over 20 State and Federal operating authorisations, allowing it to operate a fully in-house and vertically-integrated cannabis cultivation, production, manufacturing, and wholesaling supply chain, capable of supplying various LGP branded medicinal cannabis products into Australian and international markets.

The manufacturing facility was constructed with funding support from the West Australian Government and represents a regional manufacturing success story for South West Western Australia.

You might also be interested in

Export2

Company news

Export licence approved

The company has been granted an Export Licence by the Federal Department of Health

Jan 2019

Fleta Solomon MD green polo

Insights

Big plans for Little Green Pharma

Read more on the Australian firm hoping to help more UK patients benefit from medical cannabis.

Apr 2020

Pharmacy

Insights

TGA announces final CBD down-scheduling
Registered CBD products to be dispensed over-the-counter without a prescription

Dec 2020

View all articles